But these studies examined substances one at a time
Try this today: Make a note of one meal that felt okay this week
By protecting cells, reducing inflammation and improving metabolism, GLP-1 and its related drugs may offer new ways to combat age-related decline and diseases
There is no FDA-approved generic semaglutide as of 2026 because the manufacturer holds active patents on the brand-name formulations
Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al